IPCA Laboratories Limited
IPCALAB · 524494 · Healthcare · Pharmaceuticals
- Market cap
- Rs 48,868 Cr
- P/E
- 37.31x
- P/B
- 6.06x
- 52W high / low
- Rs 2,038 / Rs 1,268
About IPCA Laboratories
IPCA Laboratories Limited is listed on the NSE under the symbol IPCALAB and on the BSE under scrip code 524494. It is classified in the Healthcare sector, industry: Pharmaceuticals. It is a constituent of BSE 500, NIFTY 500, NIFTY Midcap 150 and NIFTY Pharma. The company listed on 8 Feb 1995 and has a face value of Rs 1.
The latest available end-of-day price is Rs 1,926.2 (−0.22% on the day), for a market capitalisation of Rs 48,868 Cr. Trailing P/E is 37.31x and price-to-book is 6.06x. The 52-week range is Rs 1,268 to Rs 2,038. The latest price is 85% of the way from the 52-week low to the 52-week high.
Latest annual results
For FY26 (year ended 31 Mar 2026), IPCA Laboratories Limited reported revenue of Rs 9,646 Cr and net profit of Rs 1,184 Cr, with a net margin of 12.27% and earnings per share of Rs 44.98 (consolidated statements).
Year-on-year change: revenue +8.73%; net profit +50.75%; EPS +54.68%. Three-year compound annual growth rate: revenue +15.52%; net profit +35.19%.
At the same date the balance sheet shows total assets of Rs 12,370 Cr, shareholders' equity of Rs 8,064 Cr, total debt of Rs 704 Cr, cash of Rs 437 Cr, a debt-to-equity ratio of 0.09 and operating cash flow of Rs 1,142 Cr.
On a trailing-twelve-month basis the filings add up to revenue of Rs 10,126 Cr, net income of Rs 1,375 Cr and a net margin of 13.58%.
Figures are raw disclosures from official NSE/BSE and SEBI filings plus mechanically computed ratios, restated in words. This is research data, not investment advice, a rating or a recommendation; DalalOS is not a SEBI-registered investment advisor.
More
Companies related to IPCA Laboratories
Other Healthcare companies of a similar market capitalisation
- Alkem Laboratories LimitedALKEM · Market cap Rs 60,719 Cr
- Biocon LimitedBIOCON · Market cap Rs 57,346 Cr
- Fortis Healthcare LimitedFORTIS · Market cap Rs 56,992 Cr
- Abbott India LimitedABBOTINDIA · Market cap Rs 55,558 Cr
- Gland Pharma LimitedGLAND · Market cap Rs 50,717 Cr
- Anthem Biosciences LimitedANTHEM · Market cap Rs 46,769 Cr
- Ajanta Pharma LimitedAJANTPHARM · Market cap Rs 43,367 Cr
- GlaxoSmithKline Pharmaceuticals LimitedGLAXO · Market cap Rs 42,608 Cr
Companies are grouped mechanically from the exchange classification and listed by market capitalisation. This is a comparison set, not a ranking or recommendation.